These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 8861711)

  • 1. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
    Yamano M; Ito H; Kamato T; Miyata K
    Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of inhibitory effects of serotonin (5-HT)3-receptor antagonists, YM060 and YM114 (KAE-393), on the von Bezold-Jarisch reflex induced by 2-Methyl-5-HT, veratridine and electrical stimulation of vagus nerves in anesthetized rats.
    Yamano M; Ito H; Kamato T; Miyata K
    Jpn J Pharmacol; 1995 Dec; 69(4):351-6. PubMed ID: 8786638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.
    Yamano M; Kamato T; Nishida A; Ito H; Yuki H; Tsutsumi R; Honda K; Miyata K
    Jpn J Pharmacol; 1994 Jul; 65(3):241-8. PubMed ID: 7799524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of serotonin agonists and antagonists.
    Saxena PR; Villalón CM
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S17-34. PubMed ID: 1702484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
    Miyata K; Kamato T; Yamano M; Nishida A; Ito H; Katsuyama Y; Yuki H; Tsutsumi R; Ohta M; Takeda M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):815-9. PubMed ID: 1941629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
    Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
    Miyata K; Yamano M; Kamato T; Akuzawa S
    Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats.
    Yamano M; Kamato T; Miyata K
    Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats.
    Ito C; Isobe Y; Kawamura R; Kiuchi Y; Tsuchida K; Higuchi S
    J Pharmacol Exp Ther; 1997 Jan; 280(1):67-72. PubMed ID: 8996183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
    Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
    J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
    Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
    Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
    Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of serotonin3 receptors in the nucleus tractus solitarii on the carotid chemoreflex.
    Sévoz C; Callera JC; Machado BH; Hamon M; Laguzzi R
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1250-9. PubMed ID: 9087599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.
    Minami M; Tamakai H; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):131-42. PubMed ID: 8556268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.
    Ito H; Hidaka K; Miyata K; Kamato T; Nishida A; Honda K
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1127-32. PubMed ID: 1469624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists.
    Lasheras B; Berjón A; Montañés R; Roca J; Romero G; Ramírez MJ; Del Río J
    Arzneimittelforschung; 1996 Apr; 46(4):401-6. PubMed ID: 8740088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microinjection of a 5-HT3 receptor agonist into the NTS of awake rats inhibits the bradycardic response to activation of the von Bezold-Jarisch reflex.
    Leal DM; Callera JC; Bonagamba LG; Nosjean A; Laguzzi R; Machado BH
    Brain Res Bull; 2001 Jan; 54(1):7-11. PubMed ID: 11226709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective 5-hydroxytryptamine3 (5-HT3) receptor blocking activity of KB-R6933, a novel benzimidazole derivative.
    Ozaki A; Fujishima Y; Sukamoto T
    Jpn J Pharmacol; 1999 May; 80(1):25-32. PubMed ID: 10446753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RS 23597-190: a potent and selective 5-HT4 receptor antagonist.
    Eglen RM; Bley K; Bonhaus DW; Clark RD; Hegde SS; Johnson LG; Leung E; Wong EH
    Br J Pharmacol; 1993 Sep; 110(1):119-26. PubMed ID: 8220871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.